Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018 A Nigg, M Brilhante, V Dazio, M Clément, A Collaud, SG Brawand, B Willi, ... Eurosurveillance 24 (39), 1900071, 2019 | 57 | 2019 |
Two decades of blaVIM-2-producing Pseudomonas aeruginosa dissemination: an interplay between mobile genetic elements and successful clones J Botelho, F Grosso, S Quinteira, M Brilhante, H Ramos, L Peixe Journal of Antimicrobial Chemotherapy 73 (4), 873-882, 2018 | 40 | 2018 |
Poor infection prevention and control standards are associated with environmental contamination with carbapenemase-producing Enterobacterales and other … JS Schmidt, SP Kuster, A Nigg, V Dazio, M Brilhante, H Rohrbach, ... Antimicrobial Resistance & Infection Control 9, 1-13, 2020 | 39 | 2020 |
Multidrug resistance and multivirulence plasmids in enterotoxigenic and hybrid Shiga toxin-producing/enterotoxigenic Escherichia coli isolated from diarrheic pigs in Switzerland M Brilhante, V Perreten, V Donà The Veterinary Journal 244, 60-68, 2019 | 36 | 2019 |
Employees of Swiss veterinary clinics colonized with epidemic clones of carbapenemase-producing Escherichia coli A Endimiani, M Brilhante, OJ Bernasconi, V Perreten, JS Schmidt, V Dazio, ... Journal of Antimicrobial Chemotherapy 75 (3), 766-768, 2020 | 31 | 2020 |
Evaluation of the recently launched rapid carb blue kit for detection of carbapenemase-producing gram-negative bacteria  Novais, M Brilhante, J Pires, L Peixe Journal of clinical microbiology 53 (9), 3105-3107, 2015 | 27 | 2015 |
OXA-181-producing extraintestinal pathogenic Escherichia coli sequence type 410 isolated from a dog in Portugal M Brilhante, J Menezes, A Belas, C Feudi, S Schwarz, C Pomba, ... Antimicrobial agents and chemotherapy 64 (4), 10.1128/aac. 02298-19, 2020 | 23 | 2020 |
Acquisition and carriage of multidrug‐resistant organisms in dogs and cats presented to small animal practices and clinics in Switzerland V Dazio, A Nigg, JS Schmidt, M Brilhante, N Mauri, SP Kuster, ... Journal of veterinary internal medicine 35 (2), 970-979, 2021 | 22 | 2021 |
A Novel Trimethoprim Resistance Gene, dfrA36, Characterized from Escherichia coli from Calves D Wüthrich, M Brilhante, A Hausherr, J Becker, M Meylan, V Perreten Msphere 4 (3), 10.1128/msphere. 00255-19, 2019 | 22 | 2019 |
Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral … M Brilhante, S Gobeli Brawand, A Endimiani, H Rohrbach, S Kittl, B Willi, ... Journal of Antimicrobial Chemotherapy 76 (5), 1140-1149, 2021 | 21 | 2021 |
Duration of carriage of multidrug-resistant bacteria in dogs and cats in veterinary care and co-carriage with their owners V Dazio, A Nigg, JS Schmidt, M Brilhante, EI Campos-Madueno, N Mauri, ... One Health 13, 100322, 2021 | 18 | 2021 |
PFM-like enzymes are a novel family of subclass B2 metallo-β-lactamases from Pseudomonas synxantha belonging to the Pseudomonas fluorescens complex L Poirel, M Palmieri, M Brilhante, A Masseron, V Perreten, P Nordmann Antimicrobial agents and chemotherapy 64 (2), 10.1128/aac. 01700-19, 2020 | 17 | 2020 |
Characterization of Third-Generation Cephalosporin-Resistant Escherichia coli Isolated from Pigs in Cuba Using Next-Generation Sequencing RE Hernández-Fillor, M Brilhante, CM Marrero-Moreno, M Baez, ... Microbial Drug Resistance 27 (7), 1003-1010, 2021 | 11 | 2021 |
Complete circular genome sequence of a multidrug-resistant Escherichia coli strain from Cuba obtained with Nanopore and Illumina hybrid assembly RE Hernández-Fillor, M Brilhante, I Espinosa, V Perreten Microbiology resource announcements 8 (48), 10.1128/mra. 01269-19, 2019 | 8 | 2019 |
A novel trimethoprim resistance gene, dfrA36, characterized from Escherichia coli from calves. mSphere 4: e00255-19 D Wüthrich, M Brilhante, A Hausherr, J Becker, M Meylan, V Perreten | 5 | 2019 |
Characterisation of a porcine Escherichia coli strain from Switzerland carrying mcr-1 on a conjugative multidrug resistance IncHI2 plasmid. M Brilhante, V Donà, G Overesch, A Endimiani, V Perreten Journal of global antimicrobial resistance 16, 123-124, 2018 | 5 | 2018 |
Bacteriocin dynamics in Enterococcus faecium and Enterococcus lactis: implications for clinical and commensal strain interactions AC Almeida-Santos, AP Tedim, B Duarte, M Brilhante, TM Coque, ... Scientific Letters 1 (Sup 1), 2024 | | 2024 |
Correction for Wüthrich et al. D Wüthrich, M Brilhante, A Hausherr, J Becker, M Meylan, V Perreten mSphere, 2019 | | 2019 |
Relatórios de Estágio realizado na Farmácia Ferreira de Sousa e no Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE MQ Brilhante | | 2015 |
Unveiling clones and integrons dynamics associated with carbapenemase-producing P. aeruginosa clinical isolates in a Portuguese hospital J Botelho, F Grosso, CCS Sousa, M Brilhante, C Rocha, L Peixe | | 2015 |